Treatment of rheumatoid arthritis with the dopamine agonist quinagolide
Eijsbouts, A.; van den Hoogen, F.; Laan, R.F.; Hermus, R.M.; Sweep, F.C.; van de Putte, L.
Journal of Rheumatology 26(10): 2284-2285
1999
ISSN/ISBN: 0315-162X PMID: 10529161 Document Number: 508803
Document emailed within 1 workday
Related Documents
Yamanaka, H. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. how to use the guideline in the management of rheumatoid arthritis Clinical Calcium 28(5): 607-610Suzuki, K.; Takeuchi, T. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Towards precision medicine in rheumatoid arthritis Clinical Calcium 28(5): 626-629
Malmberg; Mikaels; Mohell, N. 1998: Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding Journal of Pharmacology and Experimental Therapeutics 285(1): 119-126
Ceccherini-Nelli, A.; Guazzelli, M. 1994: Treatment of refractory OCD with the dopamine agonist bromocriptine Journal of Clinical Psychiatry 55(9): 415-416
Jenner, P. 2005: A novel dopamine agonist for the transdermal treatment of Parkinson's disease Neurology 65(2 Suppl 1): S3-S5
Sweet, R.D.; Wasterlain, C.; McDowell, F.H. 1974: Piribedil--an oral dopamine agonist for treatment of Parkinson's disease Transactions of the American Neurological Association 99: 258-260
Kohli, J.D.; Goldberg, L.I.; Volkman, P.H.; Cannon, J.G. 1978: N,N-Di-n-propyl dopamine: a qualitatively different dopamine vascular agonist Journal of Pharmacology and Experimental Therapeutics 207(1): 16-22
Hjorth, S.; Jackson, D.; Carlsson, A.; Lindberg, P. 1982: A behavioral study of the changes in the CNS of mice after subchronic treatment with the dopamine autoreceptor agonist 3-PPP Psychopharmacology Bulletin 18(4): 149-152
Yasuda, S. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Best practice in the use of T cell co-stimulatory inhibitor for patients with rheumatoid arthritis Clinical Calcium 28(5): 668-676
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
Fuller, R.W.; Clemens, J.A.; Hynes, M.D. 1982: Degree of selectivity of pergolide as an agonist at presynaptic versus postsynaptic dopamine receptors: implications for prevention or treatment of tardive dyskinesia Journal of Clinical Psychopharmacology 2(6): 371-375
Revaz, S.; Dudler, J. 2008: Diagnosis and treatment of rheumatoid vasculitis and other systemic complications of rheumatoid arthritis Revue Medicale Suisse 4(149): 712; 714 716-717
Langdon, C.G.; Moran, D.G.; Jamieson, V.; Spence, S.; Hill, S.A. 1990: A multicentre study of tenoxicam for the treatment of osteo-arthritis and rheumatoid arthritis in general practice Journal of International Medical Research 18(6): 489-496
Henrard, J.C.; Bennett, P.H.; Burch, T.A. 1974: Epidemiology of rheumatoid arthritis. Evaluation of the so-called Rome and new York criteria for the diagnosis of rheumatoid arthritis in a population study Revue du Rhumatisme et des Maladies Osteo-Articulaires 41(11): 675-683
Marhoffer, W.; Schatz, H.; Stracke, H.; Ullmann, J.; Schmidt, K.; Federlin, K. 1991: Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis Journal of Rheumatology 18(8): 1158-1162
Barrera, P.; Balsa, A.; Alves, H.; Westhovens, R.; Maenaut, K.; Cornélis, F.; Fritz, P.; Bardin, T.; Ceu Maia, M.; Lopes-Vaz, A.; Pascual Salcedo, D.; de la Concha, E.; Radstake, T.; van de Putte, L.B.; Migliorini, P.; Prudhomme, J.F.; Charron, D.; Spyropoulou, M.; Mendes, A.; Spaepen, M.; Martinez, M.; Stavropoulos, C. 2001: Noninherited maternal antigens do not increase the susceptibility for familial rheumatoid arthritis. European Consortium on Rheumatoid Arthritis Families (ECRAF) Journal of Rheumatology 28(5): 968-974
Jaller Char, J.J.; Jaller, J.A.; Waibel, J.S.; Bhanusali, D.G.; Bhanusali, N. 2018: The Role of IL-17 in the Human Immune System and its Blockage as a Treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Journal of Drugs in Dermatology: Jdd 17(5): 539-542
Chen, J.R.; Takahashi, M.; Suzuki, M.; Kushida, K.; Miyamoto, S.; Inoue, T. 1998: Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: relationship with disease activity in rheumatoid arthritis Journal of Rheumatology 25(12): 2440-2444
Scherler, M. 1978: Poncet--rheumatoid arthritis. Four cases of rheumatoid arthritis treated with tuberculostatics (author's transl1 Therapeutische Umschau. Revue Therapeutique 35(3): 201-206
De Luis, D.A.; Lahera, M.; Botella, J.I.; Valero, M.A.; Varela, C. 2001: Efficacy of quinagolide in the treatment of a patient with hypophyseal resistance to thyroid hormones Anales de Medicina Interna 18(5): 259-261